SCHEMBL10067102

SCHEMBL10067102

NC(C=O)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.42
▸ ALDH1A1 P00352 7/20 0.41
▸ POLB P06746 5/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CASP3 P42574 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ TSHR P16473 1/20 0.41
▸ GAA P10253 1/20 0.40
▸ MAOA P21397 2/20 0.39
▸ FGR P09769 1/20 0.39
▸ PIM1 P11309 1/20 0.39
▸ ADORA2A P29274 1/20 0.39
▸ CSNK1A1 P48729 1/20 0.39
▸ CSNK1D P48730 1/20 0.39
▸ DYRK1A Q13627 1/20 0.39
▸ HIPK2 Q9H2X6 1/20 0.39
▸ CSNK1G1 Q9HCP0 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ MEN1 O00255 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3259474 0.82 CASP3 (0.44) TDP1ALDH1A1POLBL3MBTL1CASP3
SCHEMBL31688086 0.75 TDP1 (0.50) TDP1ALDH1A1POLBCASP3LMNA
SCHEMBL4715603 0.75 TDP1 (0.50) TDP1ALDH1A1POLBCASP3LMNA
SCHEMBL3211204 0.74 TDP1 (0.53) TDP1ALDH1A1POLBL3MBTL1CASP3
SCHEMBL28798215 0.72 TDP1 (0.47) TDP1ALDH1A1POLBL3MBTL1CASP3
SCHEMBL11529767 0.72 ALDH1A1 (0.53) TDP1ALDH1A1POLBL3MBTL1LMNA
SCHEMBL10590551 0.72 CASP3 (0.43) TDP1ALDH1A1POLBL3MBTL1CASP3
SCHEMBL11684491 0.72 TDP1 (0.47) TDP1ALDH1A1POLBCASP3LMNA
SCHEMBL15081352 0.71 TDP1 (0.50) TDP1ALDH1A1POLBL3MBTL1CASP3
SCHEMBL11413588 0.71 TDP1 (0.46) TDP1ALDH1A1POLBL3MBTL1CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148397-B2 5-HT7 receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2012-04-03 — — US disclosed
US-7662862-B2 5-HT7 receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2010-02-16 — — US disclosed
US-7553965-B2 Central nervous system disorders; compounds are 3-sulfonamidoalkyl 2,2a,4,5-tetrahydro-1H-3-aza-acenaphthylenes LABORATORIES DEL DR. ESTEVE, S.A. (ES) 2009-06-30 — — US disclosed
Send feedback